Global Rank
#6602
Country Rank
#155
Market Cap
1.88 B
Price
7.19
Change (%)
2.93%
Volume
702,263
Lotus Pharmaceutical (TPE-1795) Stock Split History
This company has undergone a total of six stock splits throughout its history. Six forward splits were executed, enhancing liquidity and increasing share accessibility. The most recent split occurred on 10/17/2013 with a ratio of 1.071-for-1. If an investor had purchased one share prior to the first split on 09/12/2005, that single share would now have grown to 1.4047091 shares. These adjustments reflect the company's strategic efforts to align stock performance with market conditions.
Date | Split Ratio | Multiple | Cumulative multiple | Type |
---|---|---|---|---|
10/17/2013 | 1.071:1 | x1.071 | x1.404709 | Forward |
11/14/2012 | 1.042:1 | x1.042 | x1.311586 | Forward |
09/08/2010 | 1.06:1 | x1.06 | x1.25872 | Forward |
02/19/2009 | 1.038:1 | x1.038 | x1.187472 | Forward |
08/14/2008 | 1.1:1 | x1.1 | x1.144 | Forward |
09/12/2005 | 1.04:1 | x1.04 | x1.04 | Forward |
Frequently Asked Questions
-
How much would Lotus Pharmaceutical stock be worth if it never split?If Lotus Pharmaceutical (stock symbol: TPE-1795) had never undergone any stock splits, its price per share today would be approximately 10.10 USD. This calculation reflects the cumulative effect of all splits, including the most recent split (ratio: 1.071-for-1) that occurred on 10/17/2013.
-
Has Lotus Pharmaceutical stock ever split?Lotus Pharmaceutical (stock symbol: TPE-1795) has undergone a total of six stock splits. The most recent split occurred on 10/17/2013. One share bought prior to the first split on 09/12/2005 would now equal 1.40 shares.
-
Will Lotus Pharmaceutical stock split again?Lotus Pharmaceutical (stock symbol: TPE-1795) has undergone six stock splits in its history. The most recent split, a 1.04-for-1 split, occurred on 10/17/2013. While future splits are not guaranteed, significant increases in stock price could prompt consideration for another split.